TARA
Closed
Protara Therapeutics Inc
2.8
-0.2 (-6.60%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 3.03
Day's Range: 2.79 - 3.095
Send
sign up or login to leave a comment!
When Written:
3.04
Protara Therapeutics Inc. is a biopharmaceutical company that focuses on developing and commercializing therapies for rare and specialty diseases. The company's lead product candidate, TARA-002, is a potential treatment for lymphatic malformations, a rare and debilitating disease that affects the lymphatic system. Protara is also developing TARA-001, a potential treatment for intravenous iron deficiency anemia, and TARA-003, a potential treatment for pulmonary arterial hypertension. The company was founded in 2013 and is headquartered in New York, NY.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








